검색결과 : 103건
| No. | Article |
|---|---|
| 1 |
Structural basis of NR4A1 bound to the human pituitary proopiomelanocortin gene promoter Jiang LY, Wei HD, Yan NN, Dai SY, Li J, Qu LZ, Chen XJ, Guo M, Chen ZC, Chen YH Biochemical and Biophysical Research Communications, 523(1), 1, 2020 |
| 2 |
Each liver X receptor (LXR) type has a different purpose in different situations Yonezawa S, Abe M, Kawasaki Y, Natori Y, Sugiyama A Biochemical and Biophysical Research Communications, 508(1), 92, 2019 |
| 3 |
Ess2 bridges transcriptional regulators and spliceosomal complexes via distinct interacting domains Takada I, Tsuchiya M, Yanaka K, Hidano S, Takahashi S, Kobayashi T, Ogawa H, Nakagawa S, Makishima M Biochemical and Biophysical Research Communications, 497(2), 597, 2018 |
| 4 |
The ionic liquid 1-octyl-3-methylimidazolium (M8OI) is an activator of the human estrogen receptor alpha Leitch AC, Lakey AF, Hotham WE, Agius L, Kass GEN, Blain PG, Wright MC Biochemical and Biophysical Research Communications, 503(3), 2167, 2018 |
| 5 |
A Novel Nuclear Receptor Ligand, Digoxigenin, is a Selective Antagonist of Liver-X-receptors Oishi H, Takaoka Y, Nishimaki-Mogami T, Saito H, Ueda M Chemistry Letters, 46(3), 313, 2017 |
| 6 |
Modeling of drug-mediated CYP3A4 induction by using human iPS cell-derived enterocyte-like cellst Negoro R, Takayama K, Nagamoto Y, Sakurai F, Tachibana M, Mizuguchi H Biochemical and Biophysical Research Communications, 472(4), 631, 2016 |
| 7 |
Promiscuous activity of the LXR antagonist GSK2033 in a mouse model of fatty liver disease Griffett K, Burris TP Biochemical and Biophysical Research Communications, 479(3), 424, 2016 |
| 8 |
Chenodeoxycholic acid attenuates ovalbumin-induced airway inflammation in murine model of asthma by inhibiting the T(H)2 cytokines Shaik FB, Panati K, Narasimha VR, Narala VR Biochemical and Biophysical Research Communications, 463(4), 600, 2015 |
| 9 |
Rho-kinase signaling controls nucleocytoplasmic shuttling of class IIa Histone Deacetylase (HDAC7) and transcriptional activation of orphan nuclear receptor NR4A1 Compagnucci C, Barresi S, Petrini S, Bertini E, Zanni G Biochemical and Biophysical Research Communications, 459(2), 179, 2015 |
| 10 |
Suppression of atherosclerosis by synthetic REV-ERB agonist Sitaula S, Billon C, Kamenecka TM, Solt LA, Burris TP Biochemical and Biophysical Research Communications, 460(3), 566, 2015 |